C oronary artery disease (CAD) is the major cause of death in Western society. Intriguingly, in France, where there is a pattern of saturated fat intake similar to that of other Northern European countries and the United States, the incidence of CAD is 50% lower. 1 This so-called "French paradox" has fuelled considerable debate on the actual mechanism underlying this phenomenon, implicating a role for diet components and for the consumption of alcoholcontaining beverages, particularly (red) wine. [2] [3] [4] Wine is an abundant source of polyphenolic antioxidants, including catechins and gallates. Indeed, wine was shown to inhibit atherosclerosis in hyperlipidemic mice, 5 a finding that was tentatively attributed to an inhibitory effect on LDL oxidation. 6, 7 Although the antioxidant theory may be plausible, recent outcomes of 3 randomized large-scale trials failed to confirm a protective effect of the antioxidant vitamin E on CAD, 8 despite its inhibitory effect on lipid peroxidation in vivo. 9 In analogy, treatment with probucol, a bisphenolic antioxidant, yielded contradictory results, depending on animal species and strain. Red wine polyphenols may thus be atheroprotective at least in part through nonantioxidant mechanisms. Catechins were reported to inhibit platelet-derived growth factor receptor-␤ (PDGFR␤)-mediated signaling in vitro, 10 although inhibition of PDGF signaling may have an adverse effect on plaque stability, aggravating the pathobiology. 11 Resveratrol was reported to prevent platelet-leukocyte interaction and to reduce the expression of Mac-1. 12 Moreover, resveratrol and other polyphenols such as quercetin were also shown to enhance endothelial nitric oxide synthase 13 and to reduce the expression of the procoagulant activity of vascular cells. 14 Our attention was therefore drawn to gallic acid (GA), a major antioxidant constituent in red wine that has been shown to display in situ or as an alkyl derivative antioxidant 15 and anticarcinogenic 16 activity. Interestingly, we previously found that derivatization of peptide antagonists for human P-selectin with GA enhanced their affinity for P-selectin Ͼ500-fold. 17 P-selectin is an adhesion molecule that is intrincally implicated in atherothrombosis by mediating leukocyte-endothelium, leukocyte-platelet, and plateletplatelet interactions. 18, 19 The absence of P-selectin was found to result in reduced atherosclerotic lesion development and neointimal growth. 20 Recent evidence confirms that both endothelial and platelet P-selectin contribute to atherosclerosis, in agreement with the occurrence of P-selectin-dependent and platelet-assisted monocyte rolling over endothelial cells. 21 In addition, P-selectin has been associated with thrombosis because P-selectin activation induces an improvement in platelet cohesion and mediates platelet-leukocyte aggregation. 19 The surprisingly high affinity of the GAmodified peptides led us to investigate whether GA might bind and antagonize P-selectin by itself, thus providing an additional plausible explanation for the cardioprotective effect of GA and its derivatives.
Methods

Cell Culture
Chinese hamster ovary cells stably transfected with human P-selectin (CHO-P cells) were kindly donated by Dr P. Modderman (University of Amsterdam). Cells were grown in DMEM containing 10% FCS, 5 mmol/L L-glutamine, 20 000 U penicillin/streptomycin, and 5 mmol/L nonessential amino acids. Flasks with cells were incubated at 37°C in 5% CO 2 for 3 or 4 days until cells had grown nearly confluent. HL60 cells were from ATCC and grown in RPMI with 10% FCS, 5 mmol/L L-glutamine, and 20 000 U penicillin/ streptomycin.
Competition ELISA
Compounds were assayed for their ability to inhibit TM11-PO binding to human P-selectin 22 or that of biotin-PAA-Le a -SO 3 H binding to human and mouse P-selectin and to human E-and L-selectin. 23 
HL60 Adhesion Assay
HL60 cells were labeled with 5 mol/L calcein acetoxymethyl ester (calcein-AM) for 30 minutes at 37°C. HL60 cells (50 000 per well) were added to CHO-P cells (seeded in 96 well plates) in the presence or absence of GA (1 hour at 4°C). After gentle washing, fluorescence was measured.
Platelet Isolation, Labeling, and Preparation of Platelet Monolayer
Platelet-rich plasma was prepared from human 24 and murine blood 25 ; then, washed platelets were incubated for 20 minutes at 37°C with 5 mol/L calcein-AM. 21 After the platelet suspension was centrifuged at 700g for 25 minutes, fluorescent platelets were resuspended in HEPES-Tyrode's buffer. A human platelet carpet for subsequent perfusion studies was made by overnight coating of glass coverslips with calf skin collagen (1 mg/mL in 50 mmol/L acetic acid). Coverslips were then rinsed in complete Tyrode's buffer (containing 2 mmol/L CaCl 2 , 1 mmol/L MgCl 2 , and 1% human albumin). Whole human blood anticoagulated with 20 g/mL hirudin was then reperfused over the collagen-coated surface in a parallel-flow chamber at a shear rate of 300 s Ϫ1 in the presence of 1 mmol/L tirofiban (Merck). In these conditions, a homogeneous carpet of activated spread platelets formed on the coverslips without the formation of platelet aggregates.
Flow Chamber and Perfusion Studies
Dynamic interactions between HL60 cells and CHO-P cell monolayers grown on glass coverslips coated with 30 g/mL collagen S (Boehringer) were analyzed in a parallel-plate perfusion chamber as described. 21 HL60 cell translocation over CHO-P monolayers was measured at wall shear rates of 300 and 600 s Ϫ1 . GA was added to the HL60 cell suspensions 2 minutes before the start of perfusion. To prevent oxidation, the GA solution was prepared fresh. The average velocity of HL60 cells rolling over the CHO-P cells was calculated from the rolling distance of the HL60 cells in a 1-second time frame with the NIH Image program. Adhered HL60 cells were counted from pictures taken during the same experiment.
Measurements of Intracellular Ca 2؉ Concentration
HL60 cells (3ϫ10 6 ) were incubated for 10 minutes at 37°C with 100 mol/L of Quin-2 acetoxymethyl ester (Quin 2-AM), centrifuged, and resuspended in 3 mL Hanks'-HEPES buffer supplemented with CaCl 2 , glucose, and BSA. Fluorescence was measured with a Perkin Elmer LS5 fluorimeter ( ex ϭ339 nm, em ϭ492 nm) at 37°C under constant stirring (F initial ). After 1 minute, digitonin (1 L, 5 mmol/L) was added to achieve F max . F min was measured by the addition of 200 L of 500-mmol/L EGTA. GA (500 mol/L) was added 1 minute before the initial fluorescence F initial was measured. The intracellular calcium concentration (in nmol/L) was determined by (F initial ϪF min )/(F max ϪF min )ϫ115.
Leukocyte Rolling Over Collagen-Bound Platelet Monolayers
Coverslips were coated overnight with 1 mg/mL calf skin collagen in 50 mmol/L acetic acid at 4°C and then rinsed in complete Tyrode's buffer (containing 2 mmol/L CaCl 2 , 1 mmol/L MgCl 2 , and 1% human albumin) in the presence of 1 mmol/L Aggrastat. Under these conditions, a homogeneous carpet of spread platelets formed on the coverslips. Whole blood anticoagulated with 20 g/mL hirudin was reperfused in a flow chamber at a shear rate of 300 s Ϫ1 for 5 minutes at 37°C over collagen-coated glass coverslips. Blood was then progressively washed out with complete Tyrode's buffer containing 1% human albumin and perfused at a constant shear rate of 150 s Ϫ1 in the presence or absence of either 500 mol/L GA or 25 g/mL of the anti-P-selectin antibody WAPS12.2. After 3 minutes of washing, leukocytes translocating over the platelet carpet were visualized with an inverted microscope, digital movies were captured, and translocation velocity was calculated by image analysis.
In Vivo Inhibition of Endothelial Cell Inflammation
All animal experiments were reviewed and approved by the Institutional Review Board of the University of Leuven and performed in compliance with the guidelines of the International Society on Thrombosis and Hemostasis. 26 For the study of platelet-assisted leukocyte rolling over the endothelial surface of blood vessels in vivo, online video microscopy was performed in C57/Bl6 mice. Healthy wild-type (WT) mice (6 to 12 weeks old) were anesthetized with Nembutal (70 mg/kg IP), and the jugular vein was catheterized. After the femoral vein was exposed, mice were mounted on the table of an inverted epifluorescent microscope so that the blood circulation in the femoral vein could be visualized through a Cohu CCD video camera. Calcein-AM-labeled fluorescent murine platelets (500ϫ10 6 platelets in 200 L) were then injected into the catheterized jugular vein, and baseline rolling was recorded for the labeled platelets. After 10 minutes, 50 g/kg collagen and anti-␣ IIb /␤ 3 antagonist G4120 (1 mg/kg) were injected to activate circulating platelets while preventing their aggregation. After 5 minutes, the collagen-induced rolling and tumbling of leukocyte-platelet conjugates were then recorded for 10 minutes. The number of rosettes rolling was counted in the registered movies. The effect of GA on rosette rolling was investigated in 2 complementary manners. In WT mice, it was injected 5 minutes before collagen administration, and rosette rolling was analyzed as in the controls. Interactions of rosettes with the vessel wall were also studied in the femoral vein of aged atherosclerotic apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice (Ͼ1 year). In these mice, tumbling rosettes were counted 10 minutes after collagen injection to measure the steady-state rosette rolling; then, a GA bolus (0.75 to 7.5 mg/kg) was injected, followed by continuous GA infusion for up to 3 hours at 0.75 to 7.5 mg · kg Ϫ1 · h Ϫ1 , during which time GA inhibition of vessel wall inflammation was measured in real time. For clarity, unless otherwise stated, "infusion of" indicates the use of a bolus injection of a given dose followed by infusion of the same dose per hour.
Statistical Analysis
Comparisons between groups were analyzed via 2-tailed Student's t test. The ED 50 was calculated via a 4-parameter logistic curve-fitting logarithm with Grafit 3.0 software.
Results
The ability of GA to inhibit human P-selectin binding was studied in a competition assay based on a P-selectin-binding peptide (TM11, H 2 N-CDVEWVDVSSLEWDLPC-COOH). TM11-PO, a tetrameric complex between streptavidin-PO and TM11-biotin, has previously been shown to bind with high affinity and specificity to human P-selectin. 22 Interestingly, GA-derived peptides containing the consensus sequence of this peptide, like GA-(E)WVDV, displayed a considerably higher affinity for P-selectin in this competition assay (IC 50 , 15 to 37 nmol/L) 17 than the parental peptide, which bound P-selectin at micromolar concentration (IC 50 , 8 mol/L). GA by itself appeared to be a potent inhibitor of TM11-PO binding to human P-selectin at low micromolar concentrations (IC 50 , 7.2 mol/L) ( Figure 1A ).
The specificity of GA was further assessed in a competition assay based on a biotinylated sulfo-Lewis A derivatized polyacrylamide (ie, biotin-PAA-Le a -SO 3 H, an established selectin ligand) 23 because TM11-PO does not bind to E-selectin. Although GA potently inhibited human P-selectin (85 mol/L), it was ineffective against E-selectin binding (Յ20% at a concentration of 1 mmol/L; Figure 1B) , and it was a moderate inhibitor of L-selectin (IC 50 , 241 mol/L). GA binding to P-selectin appeared to be rather species independent because GA also antagonized mouse P-selectin binding with a similar affinity (IC 50 , 199 mol/L). Besides GA, n-dodecyl gallate, monophenols (4-hydroxy benzoic acid), and polyphenols [caffeic acid, and (-)-epigallocatechine gallate (EGCG)] were also tested for their capacity to antagonize human P-selectin binding (the Table) . Only GA and EGCG were able to inhibit biotin-PAA-Le a -SO 3 binding to human P-selectin. Subsequently, GA was tested in a static cellular competition assay for its ability to inhibit the adhesion of HL60 cells to CHO-P cells. These macrophage-derived HL60 cells have a high expression of P-selectin glycoprotein ligand-1 (PSGL-1), the endogenous high-affinity P-selectin ligand. 27, 28 Indeed, GA potently inhibited this interaction (IC 50 , 14 mol/L; Figure 1C ). Under dynamic flow conditions, with GA added to the HL60 cells just before perfusion, GA dose dependently increased the rolling velocity of HL60 cells across a CHO-P monolayer (wall shear rate, 150 s Ϫ1 ) at an EC 50 of 14.5 mol/L, which is essentially similar to the capacity of GA to inhibit HL60 cell adhesion (Figure 2A ). In the same experimental setup, the number of adhering HL60 cells was determined. Already at 50 mol/L, GA significantly decreased the HL60 cell adherence to the CHO-P monolayer compared with the untreated control (Ϫ34% and Ϫ43%, respectively; Figure 2B ), regardless of the wall shear rate (300 and 600 s Ϫ1 ). At 250 mol/L GA, inhibition was even more pronounced (Ϫ41% and Ϫ54%, respectively). Calcium influx in HL60 monocytes was not influenced by the addition of GA (500 mol/L), suggesting that the observed inhibitory activity of GA is not caused by modulating signal transduction ( Figure 2C ).
Flow cytometry analysis of rosette formation between activated human platelets and monocytes in human blood revealed extensive platelet binding to monocytes when platelets were activated by collagen or the tromboxane A2 analog U46619 (not shown). This binding was entirely P-selectin dependent because the neutralizing anti-P-selectin antibody WAPS12.2 prevented conjugate formation entirely ( Figure  3A) . When the rolling of resting leukocytes over a carpet of activated platelets was analyzed, GA induced a sharp rise in the rolling speed of those cells retained on the platelet surface ( Figure 3B ), reflecting impaired adhesion. However, the platelet-endothelium interaction was not disturbed because the number of activated platelets adhering to activated EAhy-926 endothelial cells remained unaltered after the addition of GA ( Figure 3C) . Similarly, GA did not affect the adherence of calcein-labeled THP-1 cells to activated EAhy-926 endo- thelial cells ( Figure 3D ). This implies that intercellular/ vascular cell adhesion molecule function is undisturbed in the presence of GA.
Injecting fluorescently labeled resting platelets into C57/ Bl6 mice did not trigger platelet rolling or platelet adhesion on the femoral vein endothelium (not shown). When circulating platelets were activated by the intravenous administration of collagen, with the concomitant injection of anti-␣ IIb /␤ 3 antagonist G4120 to avoid platelet aggregation, conjugates formed in situ between activated platelets and leukocytes. These rosettes were found to tumble along the vessel wall, as illustrated in Figure 4 , which shows in each box an individual rosette representing 2 to 3 labeled platelets attached to a single unlabeled, and thus invisible, leukocyte (individual spots in Figure 4 ). Each box consists of an overlay of a series of consecutive pictures taken at 0.1-second intervals. Calculation of the number of rolling conjugates revealed an average of 46Ϯ7 rosettes rolling across the field (0.067 mm 2 ) per minute (nϭ30 fields).
Pretreatment of mice with GA before platelet activation dose dependently reduced conjugate tumbling with an ED 50 of 1.5Ϯ0.4 mg · kg Ϫ1 · h Ϫ1 (representing the dose of a combined injection/infusion protocol as described in Methods) ( Figure  5A ). Conjugate-vessel wall interactions were almost abrogated at an infusion dose of 2.25 mg GA · kg Ϫ1 · h Ϫ1 (to 6Ϯ2 conjugates per field per minute; nϭ16 fields). Tethering of individual platelets was marginal ( Figure 6 and Data Supplement Movies).
Injection of labeled platelets into aged atherosclerotic ApoE Ϫ/Ϫ mice and subsequent in situ activation with collagen revealed increased rosette-endothelium interactions, as expected for endothelium activated by hyperlipidemia, ie, overexpressing von Willebrand factor, 24, 29 and upregulating other adhesion molecules such as intercellular adhesion molecule-1, 
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Gallic Acid Antagonizes P-Selectinvascular cell adhesion molecule-1, or E-selectin. 30 In addition to increased rosette tumbling, the femoral venous endothelium of ApoE Ϫ/Ϫ mice uncovered increased tethering of single individual platelets (Figure 6 ), in agreement with in vitro and ex vivo perfusion studies over endothelial cells and rabbit aorta endothelium. 24 In analogy to the studies in normolipidemic mice, in atherosclerotic ApoE Ϫ/Ϫ mice injected with collagen to activate platelets and preform conjugates, the infusion of 3.75 mg GA · kg Ϫ1 · h Ϫ1 also led to a sharp decrease in the number of preformed tumbling conjugates down to 34Ϯ13% of control value (PϽ0.01) without affecting single platelet tethering (Figure 5B ).
Discussion
Polyphenols, (red) wine-derived antioxidants, have received considerable attention during the last decade because they are likely to reduce the risk of CAD (the French paradox). 1 The atheroprotective effect of polyphenols has been tentatively attributed to their capacity to inhibit LDL oxidation 6, 7, 31 and to inhibit the expression of proinflammatory proteins, including PDGFR␤. 10 However, because large-scale trials have been largely inconclusive in showing an effect of other antioxidants, additional nonoxidant pathways may be at least equally prominent. The notion that red wine polyphenols act as a cardioprotective by inhibiting PDGFR␤ activity is contradicted by recent studies showing that the PDGFR␤ axis is instrumental in maintaining plaque stability and in preventing aneurysm formation by promoting vascular smooth muscle cell migration to and their proliferation in the cap. 11, 32 The present report shows that GA, one of the most abundant polyphenols in red wine, can potently intervene in P-selectin function, an adhesion molecule that is intrincally involved in the initial rolling of monocytes along the inflamed endothelium 33 and in thrombosis. 19, 34 Previously, we reported that derivatization of specific human P-selectin-binding peptides with GA led to a dramatically enhanced affinity of the peptide toward P-selectin. 17 This led to the presumption that GA by itself may specifically interact with P-selectin. Indeed, the polyphenol was found to inhibit the binding of 2 different selectin ligands, TM11-PO 22 and biotin-PAA-Le a -SO 3 H, 23 to P-selectin at micromolar affinity. Conceivably, the TM11-based assay is most reflective of the functional activity of GA, which is corroborated by the finding that static and dynamic interactions between PSGL-1 displaying HL60 cells and CHO-P monolayers were inhibited by GA. The interaction appears to be rather specific for P-selectin, although GA also displayed some affinity for L-selectin, which is in concordance with previous studies showing that the ligand binding profiles of P-and L-selectin largely overlap. 35 In vitro, GA does not disturb platelet-endothelium or leukocyte-endothelium interaction. However, GA induced a sharp rise in the rolling speed of leukocytes retained on the platelet surface, reflecting impaired adhesion. In vivo studies of platelet-assisted inflammation indicate that GA can inter- . B, Dose-dependent inhibition by GA (administered after platelet activation) of rolling of preformed leukocyte platelet conjugates over femoral vein endothelium in aged atherosclerotic ApoE Ϫ/Ϫ mice expressed relative to that of rolling in absence of GA. GA treatment consisted of single injection followed by infusion of same dose per hour (*PϽ0.05, **PϽ0.01).
rupt platelet-assisted rolling and tumbling of platelet-leukocyte rosettes over the endothelium of normocholesterolemic and hypercholesterolemic mice without affecting the deposition of single platelets on activated endothelium. This effect could be observed when GA was administered before and even after platelets had been activated.
GA effects in vitro and in vivo are not attributable to its antioxidant activity. n-Dodecyl gallate displays an antioxidant activity similar to that of GA, although it is unable to inhibit P-selectin binding at low concentrations. Similarly, other equally potent and structurally related antioxidants such as caffeic acid and dihydroxy benzoic acid are completely ineffective in inhibiting P-selectin. Finally, precautions were taken to prevent oxidation of the gallate during the experiments (which can easily be appreciated because oxidized gallate is dark green/brown).
GA is abundantly available not only in wine (grapes) but also in (green) tea. The total phenolic content in various red wines was analyzed as 1100 to 3165 mg/L, of which GA attributes 35 to 70 mg/L and the epicatechine gallate derivatives attribute 120 to 360 mg/L. 36 The GA content of green tea is even higher (2.2 mg/mL, corresponding to 149 mg/g dry leaves). 37 A study by Lee et al 38 showed that cocoa contained higher total gallate levels than green tea or red wine (611 versus 165 and 340 mg per serving, respectively). Oral administration of only 50 mg GA to a healthy volunteer resulted in plasma levels of GA and its major metabolite 4-O-methylgallic acid in the low micromolar range, 39 implying that the observed EC 50 values of 15 to 40 mol/L can be readily reached after consumption of only 100 to 500 mg GA.
In addition to being involved in atherosclerosis and thrombosis, P-selectin was reported to play a role in metastasis by promoting tumor growth and to facilitate the metastatic seeding of mucin-producing carcinomas. 40 P-selectin deficiency was shown to be accompanied by reduced implanted carcinoma cells growth and reduced metastasis formation. 40 In addition, P-selectin is expressed by several metastatic pancreatic tumor cells. 41 Thus, it is interesting that Ohno et al 42 recently demonstrated that GA administration (50 mg/kg) could inhibit metastasis formation and growth.
In conclusion, GA inhibits P-selectin-mediated inflammation both in vitro and in vivo. This study provides for the first time a molecular mechanism through which GA can exert a beneficial effect in several pathobiologies such as CAD, thrombosis, and cancer by binding and antagonizing P-selectin under static and dynamic conditions already at concentrations readily achieved after moderate wine, (green) tea, or cocoa consumption. 
